Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevity.

Stoyanov, Evgeniy; Mizrahi, Lina; Olam, Devorah; Schnitzer-Perlman, Temima; Galun, Eithan; Goldenberg, Daniel S

Stoyanov, Evgeniy; Mizrahi, Lina; Olam, Devorah; Schnitzer-Perlman, Temima; Galun, Eithan; Goldenberg, Daniel S.

Afiliación

Stoyanov E; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Mizrahi L; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Olam D; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Schnitzer-Perlman T; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Galun E; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Goldenberg DS; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Oncotarget ; 8(62): 104772-104784, 2017 Dec 01.

Article en En | MEDLINE | ID: mdl-29285212

Palabras clave

Abcb4; Mdr2; S-adenosylmethionine; hepatocellular carcinoma; methionine adenosyltransferase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google